Oxybutynin is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Ncs Healthcare Of Ky, Inc Dba Vangard Labs. The primary component is Oxybutynin Chloride.
Product ID | 0615-8220_14ea75ea-9afc-44c8-95f4-d08aef313e45 |
NDC | 0615-8220 |
Product Type | Human Prescription Drug |
Proprietary Name | Oxybutynin |
Generic Name | Oxybutynin |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2017-08-10 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA202332 |
Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
Substance Name | OXYBUTYNIN CHLORIDE |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-06-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA202332 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-06-28 |
Ingredient | Strength |
---|---|
OXYBUTYNIN CHLORIDE | 10 mg/1 |
SPL SET ID: | ec4fd95f-16dc-4acf-b560-b67b7aaef08b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0615-8219 | oxybutynin | oxybutynin |
0615-8220 | Oxybutynin | Oxybutynin |
50090-5352 | oxybutynin | oxybutynin |
50090-5353 | oxybutynin | oxybutynin |
68382-255 | oxybutynin | oxybutynin |
68382-256 | oxybutynin | oxybutynin |
68382-257 | oxybutynin | oxybutynin |
70518-1457 | oxybutynin | oxybutynin |
70518-2331 | oxybutynin | oxybutynin |
70771-1086 | oxybutynin | oxybutynin |
70771-1087 | oxybutynin | oxybutynin |
70771-1088 | oxybutynin | oxybutynin |
71335-0974 | oxybutynin | oxybutynin |
0023-6153 | OXYTROL | Oxybutynin |
52544-920 | OXYTROL | Oxybutynin |
0023-9637 | Oxytrol for Women | Oxybutynin |
52544-166 | Oxytrol For Women | oxybutynin |